Single-cell RNA sequencing uncovers heterogenous immune cell responses upon exposure to food additive (E171) titanium dioxide
The prospective use of food additive titanium dioxide (E171 TiO<sub>2</sub>) in a variety of fields (food, pharmaceutics, and cosmetics) prompts proper cellular cytotoxicity and transcriptomic assessment. Interestingly, smaller-sized E171 TiO<sub>2</sub> can translocate in bloodstream and induce a diverse immunological response by activating the immune system, which can be either pro-inflammatory or immune-suppressive. Nevertheless, their cellular or immunologic responses in a heterogeneous population of the immune system following exposure of food additive E171 TiO<sub>2</sub> is yet to be elucidated. For this purpose, we have used male Sprague-Dawley rats to deliver E171 TiO<sub>2</sub> (5 mg/kg bw per day) via non-invasive intratracheal instillation for 13 weeks. After the 4 weeks recovery period, 3 mL of blood samples from both treated and untreated groups were collected for scRNAseq analysis. Firstly, granulocyte G1 activated innate immune response through the upregulation of genes involved in pro-inflammatory cytokine mediated cytotoxicity. Whereas NK cells resulted in heterogeneity role depending on the subsets where NK1 significantly inhibited cytotoxicity, whereas NK2 and NK3 subsets activated pro-B cell population & inhibited T cell mediated cytotoxicity respectively. While NKT_1 activated innate inflammatory responses which was confirmed by cytotoxic CD8+ T killer cell suppression. Similarly, NKT_2 cells promote inflammatory response by releasing lytic granules and MHC-I complex inhibition to arrest cytotoxic T killer cell responses. Conversely, NKT_3 suppressed inflammatory response by release of anti-inflammatory cytokines suggesting the functional heterogeneity of NKT subset. The formation of MHC-I or MHC-II complexes with T-cell subsets resulted in neither B and T cell dysfunction nor cytotoxic T killer cell inhibition suppressing adaptive immune response. Overall, our research offers an innovative high-dimensional approach to reveal immunological and transcriptomic responses of each cell types at the single cell level in a complex heterogeneous cellular environment by reassuring a precise assessment of immunological response of E171 TiO<sub>2</sub>.
Authors
- Hyoung‐Yun Han (ORCID: https://orcid.org/0000-0002-7957-7448)
- Hyun‐Yi Kim
- Haribalan Perumalsamy (ORCID: https://orcid.org/0000-0002-6497-5857)
- Seokjoo Yoon
- Tae Hyun Yoon (ORCID: https://orcid.org/0000-0002-2743-6360)
- Tae Geol Lee (ORCID: https://orcid.org/0000-0002-6674-4147)
- Min Beom Heo (ORCID: https://orcid.org/0000-0003-0863-5097)
- Xiao Xiao (ORCID: https://orcid.org/0009-0009-2252-6613)
- Jung-Hwa Oh (ORCID: https://orcid.org/0000-0002-3348-3120)
Institutions
- Korea Research Institute of Standards and Science (KR)
- Korea Institute of Toxicology (KR)
- Insilicogen (South Korea) (KR)
- Hanyang University (KR)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12951-024-03036-9
- Citations
- 2
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.49
Funders
- European Commission
- National Research Foundation
- National Research Foundation of Korea
- Horizon 2020 Framework Programme
- HORIZON EUROPE Framework Programme